Literature DB >> 31241128

Functional balance between Tcf21-Slug defines cellular plasticity and migratory modalities in high grade serous ovarian cancer cell lines.

Sagar S Varankar1, Madhuri More1, Ancy Abraham1, Kshama Pansare2, Brijesh Kumar1, Nivedhitha J Narayanan1, Mohit Kumar Jolly3, Avinash M Mali1, Sharmila A Bapat1.   

Abstract

Cellular plasticity and transitional phenotypes add to complexities of cancer metastasis that can be initiated by single cell epithelial to mesenchymal transition (EMT) or cooperative cell migration (CCM). Our study identifies novel regulatory cross-talks between Tcf21 and Slug in mediating phenotypic and migration plasticity in high-grade serous ovarian adenocarcinoma (HGSC). Differential expression and subcellular localization associate Tcf21, Slug with epithelial, mesenchymal phenotypes, respectively; however, gene manipulation approaches identify their association with additional intermediate phenotypic states, implying the existence of a multistep epithelial-mesenchymal transition program. Live imaging further associated distinct migratory modalities with the Tcf21/Slug status of cell systems and discerned proliferative/passive CCM, active CCM and EMT modes of migration. Tcf21-Slug balance identified across a phenotypic spectrum in HGSC cell lines, associated with microenvironment-induced transitions and the emergence of an epithelial phenotype following drug exposure. Phenotypic transitions and associated functionalities following drug exposure were affirmed to ensue from occupancy of Slug promoter E-box sequences by Tcf21. Our study effectively provides a framework for understanding the relevance of ovarian cancer plasticity as a function of two transcription factors.
© The Author(s) 2019. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Year:  2020        PMID: 31241128     DOI: 10.1093/carcin/bgz119

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  6 in total

1.  Testing the gene expression classification of the EMT spectrum.

Authors:  Dongya Jia; Jason T George; Satyendra C Tripathi; Deepali L Kundnani; Mingyang Lu; Samir M Hanash; José N Onuchic; Mohit Kumar Jolly; Herbert Levine
Journal:  Phys Biol       Date:  2019-01-18       Impact factor: 2.583

Review 2.  Interconnected high-dimensional landscapes of epithelial-mesenchymal plasticity and stemness in cancer.

Authors:  Sarthak Sahoo; Bazella Ashraf; Atchuta Srinivas Duddu; Adrian Biddle; Mohit Kumar Jolly
Journal:  Clin Exp Metastasis       Date:  2022-01-07       Impact factor: 5.150

Review 3.  Dynamics of Phenotypic Heterogeneity Associated with EMT and Stemness during Cancer Progression

Authors:  Mohit Kumar Jolly; Toni Celià-Terrassa
Journal:  J Clin Med       Date:  2019-09-25       Impact factor: 4.241

4.  The Extracellular Matrix Influences Ovarian Carcinoma Cells' Sensitivity to Cisplatinum: A First Step towards Personalized Medicine.

Authors:  Andrea Balduit; Chiara Agostinis; Alessandro Mangogna; Veronica Maggi; Gabriella Zito; Federico Romano; Andrea Romano; Rita Ceccherini; Gabriele Grassi; Serena Bonin; Deborah Bonazza; Fabrizio Zanconati; Giuseppe Ricci; Roberta Bulla
Journal:  Cancers (Basel)       Date:  2020-05-07       Impact factor: 6.639

Review 5.  Hypoxia, partial EMT and collective migration: Emerging culprits in metastasis.

Authors:  Kritika Saxena; Mohit Kumar Jolly; Kuppusamy Balamurugan
Journal:  Transl Oncol       Date:  2020-08-08       Impact factor: 4.243

6.  Comparative Study of Transcriptomics-Based Scoring Metrics for the Epithelial-Hybrid-Mesenchymal Spectrum.

Authors:  Priyanka Chakraborty; Jason T George; Shubham Tripathi; Herbert Levine; Mohit Kumar Jolly
Journal:  Front Bioeng Biotechnol       Date:  2020-03-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.